Screening Protocol for the Evaluation of Potential Research Subjects
2 other identifiers
observational
6,967
1 country
1
Brief Summary
Background: \- The Neuroimaging Research Branch of the National Institute on Drug Abuse (NIDA) is interested in developing a pool of potential research participants who may be eligible for research studies on drug abuse and addiction, pharmacological and psychosocial therapies for substance addiction, and the long-term effects of drugs on the development, function, and structure of the brain and other organ systems. To develop this pool of potential participants, researchers intend to screen adolescents and adults who may be eligible for future research studies. Objectives: \- To identify, recruit, and screen participants for NIDA neuroimaging research protocols. Eligibility: \- Individuals 18 years of age and older who are able to provide informed consent. Design:
- Eligible participants will undergo two screening interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview. Adolescents who are eligible for further screening must bring a parent or guardian with them to the in-person interview.
- The in-person interview may require up to five visits to the NIDA clinical center. The in-person visit will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff.
- During the screening process, participants will be explicitly asked for permission to recontact them after the 1-year duration of the screening protocol. For minors, both the adolescent and the parent/guardian must agree to future contact.
- No clinical care will be provided under this protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 23, 2006
CompletedFirst Submitted
Initial submission to the registry
December 18, 2009
CompletedFirst Posted
Study publicly available on registry
December 21, 2009
CompletedApril 2, 2026
December 17, 2025
December 18, 2009
April 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Screening for NIDA studies
Screening for NIDA studies
baseline
Study Arms (1)
1
potential research subjects
Eligibility Criteria
Screening protocol for all NIDA clinical studies
You may qualify if:
- Males and females ages 18 or older.
You may not qualify if:
- Phone screen: Subjects who are unable to understand or adequately answer questions posed in the phone screen.
- Phone screen and in-person screen: Subjects unable to provide informed consent.
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute on Drug Abuse, Biomedical Research Center (BRC)
Baltimore, Maryland, 21224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lorenzo Leggio, M.D.
National Institute on Drug Abuse (NIDA)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2009
First Posted
December 21, 2009
Study Start
August 23, 2006
Last Updated
April 2, 2026
Record last verified: 2025-12-17
Data Sharing
- IPD Sharing
- Will not share
No plan depicted in protocol.